TY - JOUR
T1 - Genotype-Phenotype Correlation in WT1 Exon 8 to 9 Missense Variants
AU - Nagano, China
AU - Takaoka, Yutaka
AU - Kamei, Koichi
AU - Hamada, Riku
AU - Ichikawa, Daisuke
AU - Tanaka, Kazuki
AU - Aoto, Yuya
AU - Ishiko, Shinya
AU - Rossanti, Rini
AU - Sakakibara, Nana
AU - Okada, Eri
AU - Horinouchi, Tomoko
AU - Yamamura, Tomohiko
AU - Tsuji, Yurika
AU - Noguchi, Yuko
AU - Ishimori, Shingo
AU - Nagase, Hiroaki
AU - Ninchoji, Takeshi
AU - Iijima, Kazumoto
AU - Nozu, Kandai
N1 - Publisher Copyright:
© 2021 International Society of Nephrology
PY - 2021/8
Y1 - 2021/8
N2 - Introduction: WT1 missense mutation in exon 8 or 9 causes infantile nephrotic syndrome with early progression to end-stage kidney disease (ESKD), Wilms tumor, and 46,XY female. However, some patients with missense mutations in exon 8 or 9 progress to ESKD in their teens or later. Therefore, we conducted a systematic review and functional analysis of WT1 transcriptional activity. Methods: We conducted a systematic review of 174 cases with WT1 exon 8 or 9 missense variants from our cohort (n=13) and previous reports (n=161). Of these cases, mild and severe genotypes were selected for further in vitro functional analysis using luciferase assay. Results: The median age of developing ESKD was 1.17 years. A comparative study was conducted among three WT1 genotype classes: mutations of the DNA-binding site (DBS group), mutations outside the DNA-binding site but at sites important for zinc finger structure formation by 2 cysteines and 2 histidines (C2H2 group), and mutations leading to other amino acid changes (Others group). The DBS group showed the severest phenotype and the C2H2 group was intermediate, whereas the Others group showed the mildest phenotype (developing ESKD at 0.90, 2.00, and 3.92 years, respectively, with significant differences). In vitro functional analysis showed dominant-negative effects for all variants; in addition, the DBS and C2H2 mutations were associated with significantly lower WT1 transcriptional activity than the other mutations. Conclusion: Not only the DNA-binding site but also C2H2 zinc finger structure sites are important for maintaining WT1 transcriptional activity, and their mutation causes severe clinical symptoms.
AB - Introduction: WT1 missense mutation in exon 8 or 9 causes infantile nephrotic syndrome with early progression to end-stage kidney disease (ESKD), Wilms tumor, and 46,XY female. However, some patients with missense mutations in exon 8 or 9 progress to ESKD in their teens or later. Therefore, we conducted a systematic review and functional analysis of WT1 transcriptional activity. Methods: We conducted a systematic review of 174 cases with WT1 exon 8 or 9 missense variants from our cohort (n=13) and previous reports (n=161). Of these cases, mild and severe genotypes were selected for further in vitro functional analysis using luciferase assay. Results: The median age of developing ESKD was 1.17 years. A comparative study was conducted among three WT1 genotype classes: mutations of the DNA-binding site (DBS group), mutations outside the DNA-binding site but at sites important for zinc finger structure formation by 2 cysteines and 2 histidines (C2H2 group), and mutations leading to other amino acid changes (Others group). The DBS group showed the severest phenotype and the C2H2 group was intermediate, whereas the Others group showed the mildest phenotype (developing ESKD at 0.90, 2.00, and 3.92 years, respectively, with significant differences). In vitro functional analysis showed dominant-negative effects for all variants; in addition, the DBS and C2H2 mutations were associated with significantly lower WT1 transcriptional activity than the other mutations. Conclusion: Not only the DNA-binding site but also C2H2 zinc finger structure sites are important for maintaining WT1 transcriptional activity, and their mutation causes severe clinical symptoms.
KW - DNA binding
KW - WT1
KW - end-stage kidney disease
KW - transcriptional activity
UR - http://www.scopus.com/inward/record.url?scp=85109093270&partnerID=8YFLogxK
U2 - 10.1016/j.ekir.2021.05.009
DO - 10.1016/j.ekir.2021.05.009
M3 - 学術論文
C2 - 34386660
AN - SCOPUS:85109093270
SN - 2468-0249
VL - 6
SP - 2114
EP - 2121
JO - Kidney International Reports
JF - Kidney International Reports
IS - 8
ER -